Close Menu

NEW YORK (GenomeWeb) – Swiss startup Scailyte announced yesterday that it has raised CHF 2.8 million (US $2.8 million) in a seed funding round.

The Luzern, Switzerland-based firm will use the capital to improve market entry and to expedite development of ScaiVision, an artificial intelligence-based software that analyzes single-cell data to enhance biomedical research, pharmaceutical discovery, and precision diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.